IL17A and psoriasis: Although IL-22-producing Th22 cells were first discovered in psoriatic lesions, it is widely accepted that IL-17- and IL-22- expressing Th17 cells drive the inflammatory cascades and activate and recruit Th1 cells and Th22 cells, resulting in abnormal immune response and aberrant epidermal proliferation in psoriasis (149).